These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

69 related articles for article (PubMed ID: 4253758)

  • 1. [Accelerated erythrocyte sedimentation induced in experimental animals as a pharmacological method].
    von Eickstedt KW
    Naunyn Schmiedebergs Arch Pharmakol; 1970; 266(4):316-7. PubMed ID: 4253758
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of drugs on platelet aggregation: attempt at quantitative comparison of inhibitory effects.
    Cepelák V; Cepeláková H; Roubal Z; Nĕmecek O
    Acta Univ Carol Med Monogr; 1972; 53():221-7. PubMed ID: 4670731
    [No Abstract]   [Full Text] [Related]  

  • 3. Newly synthesized pyrazolidine derivatives as potential activators of fibrinolysis and antiaggregating agents.
    Roubal Z; Cepelák V; Nĕmecek O
    Acta Univ Carol Med Monogr; 1972; 52():49-54. PubMed ID: 4669826
    [No Abstract]   [Full Text] [Related]  

  • 4. Biochemical investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 4. Effects on erythrocyte membrane lysis and on red cells aggregation.
    Coppi G; Bonardi G
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:247-9. PubMed ID: 5067201
    [No Abstract]   [Full Text] [Related]  

  • 5. [Physiological activity and some physico-chemical properties of acyl derivatives of pyrazolone].
    Saratikov AS; Lomov NI; Syrneva NV; Chernova NA; Prushchep TP; Lavrent'eva LN; Shchipkova LG
    Farmakol Toksikol; 1968; 31(4):437-41. PubMed ID: 5698134
    [No Abstract]   [Full Text] [Related]  

  • 6. [Basically substituted 4-acylaminophenazones: synthesis and pharmacological effect].
    Mühle H; Ernst L; Meier W; Renker H
    Arzneimittelforschung; 1968 Jul; 18(7):850-4. PubMed ID: 5755832
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacological studies of a new anti-inflammatory drug, 1-phenylsulfonyl-5,5-diphenylhydantoin (PC-796) in experimental animals. I. Anti-inflammatory, analgesic and anti-pyretic activity.
    Nakamura H; Kadokawa T; Nakatsuji K; Nakamura K
    Arzneimittelforschung; 1970 Aug; 20(8):1032-46. PubMed ID: 5536496
    [No Abstract]   [Full Text] [Related]  

  • 8. Biochemical investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 2. Action on local and systemic chemical responses in the rat with an experimental inflammatory process.
    Coppi G; Bonardi G
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:237+. PubMed ID: 5067200
    [No Abstract]   [Full Text] [Related]  

  • 9. Interaction of a new antiphlogistic drug with histamine, bradykinin and tissue kinins.
    Tubaro E
    Boll Chim Farm; 1969 Feb; 108(2):100-7. PubMed ID: 4394623
    [No Abstract]   [Full Text] [Related]  

  • 10. [Comparison of some antiphlogistics in the systems of neoplastic cells].
    Warnecke P; Seeber S
    Arzneimittelforschung; 1969 Jun; 19(6):975-7. PubMed ID: 5820042
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of some anti-inflammatory drugs on the ATP-content and cell proliferation of neoplastic mast cells in vitro].
    Kalbhen DA; Lynen J
    Arzneimittelforschung; 1968 Dec; 18(12):1506-12. PubMed ID: 4975660
    [No Abstract]   [Full Text] [Related]  

  • 12. [Synthesis and pharmacological properties of pyrazole compounds. II. 4-aminopyrazole derivatives variously substituted in the 1 position].
    Bianchi M; Bonacina F; Osvaldo A; Pirola C
    Farmaco Sci; 1970 Aug; 25(8):592-617. PubMed ID: 5491604
    [No Abstract]   [Full Text] [Related]  

  • 13. Chemical induction of fibrinolysis and inhibition of platelet aggregation (with special respect to effect of nonsteroid antiinflammatory drugs).
    Cepelák V; Roubal Z; Cepeláková H; Nĕmecek O
    Acta Univ Carol Med Monogr; 1972; 52():41-7. PubMed ID: 4669825
    [No Abstract]   [Full Text] [Related]  

  • 14. [Method of testing for capillary permeability].
    Fujimura H; Tsurumi K; Hayashi M
    Nihon Yakurigaku Zasshi; 1968 May; 64(3):379-84. PubMed ID: 5749308
    [No Abstract]   [Full Text] [Related]  

  • 15. Drug influence on platelet loss during extracorporeal circulation.
    Mielke CH; de Leval M; Hill JD; Macur MF; Gerbode F
    J Thorac Cardiovasc Surg; 1973 Dec; 66(6):845-54. PubMed ID: 4759692
    [No Abstract]   [Full Text] [Related]  

  • 16. Pharmacological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 3. General pharmacological properties.
    Bianchi C; Bonardi G
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:196+. PubMed ID: 5067191
    [No Abstract]   [Full Text] [Related]  

  • 17. [The pharmacology of anti-inflammatory agents].
    Estler CJ
    Zahnarztl Mitt; 1979 Jun; 69(11):671-9. PubMed ID: 288273
    [No Abstract]   [Full Text] [Related]  

  • 18. The effect of antipyretics on the erythrocytic sedimentation rate of rats.
    WENZEL DG; BEAL JL; HASKELL AR
    J Am Pharm Assoc Am Pharm Assoc; 1953 Oct; 42(10):600-1. PubMed ID: 13096398
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of pyrazolidine and coumarin derivatives on bleeding time and prothrombin level in rats.
    Cepeláková H; Roubal Z; Grimová J; Dlabac A; Cepelák V
    Acta Univ Carol Med Monogr; 1972; 52():55-60. PubMed ID: 4669827
    [No Abstract]   [Full Text] [Related]  

  • 20. [Biochemical mechanisms of the action of non-steroid anti-inflammatory agents (literature review)].
    Trinus FP; Klebanov BM
    Farmakol Toksikol; 1972; 35(1):112-7. PubMed ID: 4401745
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.